Pharmaceutical company AbbVie is buying ImmunoGen in a deal valued at about $10.1 billion that will speed up its entry into the commercial market for ovarian cancer

Rising interest rates in the US and Europe are forcing environmentally focused investors to rethink a market long-considered

The three-year run of investors pouring cash into stocks has run out of steam, according to a note

TOKYO - Japan's manufacturing activity fell back into contraction in June and service sector growth slowed for the first time

By Lucia Mutikani WASHINGTON U.S. growth likely slowed in June after surging in the prior two months, but

CHARLOTTE, N.C.--(BUSINESS WIRE)--Jun 20, 2023--

Deere & Co. lifted its financial outlook for the year as machinery demand from farmers remained robust despite

European Central Bank President Christine Lagarde reiterated that borrowing costs will remain elevated for as long as needed

Warner Bros. has pushed back the hotly anticipated release of sci-fi sequel "Dune: Part Two" until next year and postponed two other films -- one of the biggest changes so far to the movie calendar...

TL;DR: A lifetime subscription to the 2023 CompTIA and IT Exam Study Guide Training Bundle

NEW YORK & HANOI, Vietnam--(BUSINESS WIRE)--Aug 15, 2023--

Cava Group Inc. expects higher profits this year, although it cautioned that a muddy consumer-spending picture could limit